(Q30573127)

10 August 2017

1 reference

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis (English)

1 reference

extensively drug-resistant tuberculosis

10 August 2017

0 references

0 references

1 reference

1 reference

K DeRiemer

5

0 references

Rosella Centis

R Centis

6

0 references

Giovanni Sotgiu

G Sotgiu

Giovanni Battista Migliori

2

0 references

1

G B Migliori

1 reference

10 August 2017

Shaf Baloch Keshavjee

16

S Keshavjee

1 reference

ORCID Public Data File 2021

10 August 2017

1 reference

Helen Cox

1 reference

ORCID Public Data File 2021

Tjip S van der Werf

1 reference

ORCID Public Data File 2021

author name string

N R Gandhi

3

1 reference

10 August 2017

D Falzon

4

1 reference

10 August 2017

M G Hollm-Delgado

7

1 reference

10 August 2017

D Palmero

8

1 reference

10 August 2017

C Pérez-Guzmán

9

1 reference

10 August 2017

M H Vargas

10

1 reference

10 August 2017

L D'Ambrosio

11

1 reference

10 August 2017

A Spanevello

12

1 reference

10 August 2017

M Bauer

13

1 reference

10 August 2017

E D Chan

14

1 reference

10 August 2017

H S Schaaf

15

1 reference

10 August 2017

T H Holtz

17

1 reference

10 August 2017

D Menzies

18

1 reference

10 August 2017

“The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB”

19

1 reference

10 August 2017

11 October 2012

1 reference

European Respiratory Journal

10 August 2017

1 reference

10 August 2017

42

1 reference

10 August 2017

1

1 reference

10 August 2017

169-179

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

10 August 2017

1 reference

Rediscovering high technology from the past: thoracic surgery is back on track for multidrug-resistant tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Delamanid for multidrug-resistant pulmonary tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

European union standards for tuberculosis care

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

First tuberculosis cases in Italy resistant to all tested drugs.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Worldwide emergence of extensively drug-resistant tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Quantifying heterogeneity in a meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Totally drug-resistant tuberculosis in India.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Extensively drug-resistant tuberculosis in the United States, 1993-2007.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

Drug treatment of tuberculosis. II. Treatment of patients with tubercle bacilli resistant to standard chemotherapy.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4498806

The chemotherapy of tuberculosis. With special reference to patients whose bacilli are resistant to the standard drugs

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23060633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23060633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23060633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1183/09031936.00136312

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

23060633

1 reference